tiprankstipranks
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
Holding SGMO?
Track your performance easily

Sangamo Biosciences (SGMO) Financial Statements

1,919 Followers

Sangamo Biosciences Financial Overview

Sangamo Biosciences's market cap is currently ―. The company's EPS TTM is $-0.745; its P/E ratio is -2.55; Sangamo Biosciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 49.41M$ 356.00K$ 481.00K$ 2.04M$ 9.40M
Gross Profit$ 49.41M$ 356.00K$ 481.00K$ 2.04M$ 9.40M
EBIT$ 10.76M$ -36.05M$ -48.99M$ -61.76M$ -61.61M
EBITDA$ 12.89M$ -33.21M$ -46.74M$ -58.75M$ -54.19M
Net Income Common Stockholders$ 10.67M$ -36.13M$ -49.09M$ -60.30M$ -104.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.20M$ 27.79M$ 54.42M$ 81.00M$ 132.11M
Total Assets$ 111.26M$ 93.01M$ 128.96M$ 165.32M$ 219.70M
Total Debt$ 27.73M$ 29.10M$ 30.82M$ 33.52M$ 34.98M
Net Debt$ -11.47M$ 1.31M$ -23.60M$ -47.49M$ -97.14M
Total Liabilities$ 72.13M$ 69.32M$ 72.26M$ 82.43M$ 84.78M
Stockholders Equity$ 39.13M$ 23.69M$ 56.70M$ 82.89M$ 134.92M
Cash Flow-
Free Cash Flow$ 11.99M$ -26.76M$ -48.66M$ -53.21M$ -50.04M
Operating Cash Flow$ 11.76M$ -26.88M$ -48.66M$ -50.54M$ -47.29M
Investing Cash Flow$ 233.00K$ 127.00K$ 35.84M$ 37.71M$ 37.63M
Financing Cash Flow$ -203.00K$ -533.00K$ 22.12M$ 167.00K$ -100.00K
Currency in USD

Sangamo Biosciences Earnings and Revenue History

Sangamo Biosciences Debt to Assets

Sangamo Biosciences Cash Flow

Sangamo Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis